A new method to help regenerate cartilage using a special scaffold
A Bio-inspired Latent TGF-beta Conjugated Scaffold for Patient-specific Cartilage Regeneration
['FUNDING_R01'] · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · NIH-11136853
This study is testing a new way to help heal damaged cartilage by using a special gel that releases a growth factor in a smart way, which could lead to better and more even cartilage repair for patients.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11136853 on ClinicalTrials.gov |
What this research studies
This research focuses on improving cartilage regeneration by using a bio-inspired scaffold that delivers transforming growth factor beta (TGF-β) in a more effective way. Instead of relying on traditional methods that can lead to uneven growth or poor-quality cartilage, this approach mimics the natural process where TGF-β is stored in an inactive form and activated as needed. By encapsulating chondrogenic cells in a hydrogel scaffold that releases TGF-β in a controlled manner, the research aims to enhance the quality and uniformity of cartilage repair. Patients may benefit from this innovative technique if it proves successful in clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from cartilage damage or degeneration, such as those with osteoarthritis or sports-related injuries.
Not a fit: Patients with non-cartilage related musculoskeletal issues or those who do not have cartilage damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for cartilage injuries and degenerative conditions, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using bio-inspired scaffolds for tissue engineering, suggesting that this approach could be effective.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALBRO, MICHAEL B — BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
- Study coordinator: ALBRO, MICHAEL B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.